These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1638549)

  • 1. Transforming growth factor-beta.
    Massagué J; Cheifetz S; Laiho M; Ralph DA; Weis FM; Zentella A
    Cancer Surv; 1992; 12():81-103. PubMed ID: 1638549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
    Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
    Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: a general review.
    Lawrence DA
    Eur Cytokine Netw; 1996 Sep; 7(3):363-74. PubMed ID: 8954178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta: the breaking open of a black box.
    Alevizopoulos A; Mermod N
    Bioessays; 1997 Jul; 19(7):581-91. PubMed ID: 9230691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transforming growth factor beta. A potent multifunctional growth factor for normal and malignant cells].
    Nørgaard P; Damstrup L; Spang-Thomsen M; Poulsen HS
    Ugeskr Laeger; 1992 Nov; 154(49):3494-8. PubMed ID: 1334294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
    Chegini N
    Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
    Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
    Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factors-beta as regulators of cellular growth and phenotype.
    Laiho M; Keski-Oja J
    Crit Rev Oncog; 1992; 3(1-2):1-26. PubMed ID: 1312867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor beta in mouse osteoblastic cells.
    Ghayor C; Rey A; Caverzasio J
    Bone; 2005 Jan; 36(1):93-100. PubMed ID: 15664007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.
    Dooley S; Delvoux B; Lahme B; Mangasser-Stephan K; Gressner AM
    Hepatology; 2000 May; 31(5):1094-106. PubMed ID: 10796885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
    Danielpour D
    J Cell Physiol; 1996 Jan; 166(1):231-9. PubMed ID: 8557772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR; Hromchak R; Mudipalli A; Bloch A
    Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer.
    Brunschwig EB; Wilson K; Mack D; Dawson D; Lawrence E; Willson JK; Lu S; Nosrati A; Rerko RM; Swinler S; Beard L; Lutterbaugh JD; Willis J; Platzer P; Markowitz S
    Cancer Res; 2003 Apr; 63(7):1568-75. PubMed ID: 12670906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.